ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 49 filers reported holding ATYR PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $521,000 | -71.8% | 572,489 | -18.0% | 0.01% | -66.7% |
| Q1 2018 | $1,850,000 | -25.0% | 698,234 | -0.9% | 0.02% | -25.0% |
| Q4 2017 | $2,466,000 | -35.3% | 704,524 | -6.6% | 0.02% | -28.6% |
| Q3 2017 | $3,810,000 | +33.5% | 754,524 | -10.1% | 0.03% | +16.7% |
| Q2 2017 | $2,853,000 | +0.7% | 839,264 | +3.7% | 0.02% | +4.3% |
| Q1 2017 | $2,834,000 | +23.0% | 809,642 | -24.5% | 0.02% | +21.1% |
| Q4 2016 | $2,305,000 | -30.3% | 1,072,108 | +3.1% | 0.02% | -38.7% |
| Q3 2016 | $3,308,000 | +25.2% | 1,040,135 | +9.4% | 0.03% | +24.0% |
| Q2 2016 | $2,642,000 | +36.6% | 950,461 | +93.7% | 0.02% | +38.9% |
| Q1 2016 | $1,934,000 | -36.3% | 490,750 | +58.8% | 0.02% | -43.8% |
| Q4 2015 | $3,038,000 | +60.7% | 309,062 | +67.8% | 0.03% | +45.5% |
| Q3 2015 | $1,890,000 | -32.1% | 184,177 | +22.6% | 0.02% | +37.5% |
| Q2 2015 | $2,782,000 | – | 150,240 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |